The nervous system plays an integral role in the functioning of the human body, responsible for transmitting messages from the brain to the rest of the organs. When this system breaks down, it can cause a variety of conditions. A few common diseases of the nervous system include Alzheimer’s disease, stroke, multiple sclerosis, Parkinson’s disease, motor neuron disease, and epilepsy. Alzheimer’s dementia is a chronic and progressive brain disorder caused by disturbances in the brain’s pathways. It most commonly affects the elderly and is characterized by memory loss and difficulty with problem solving or language processing. Despite having no known cure, scientists are looking into ways to target the root causes of the condition. Stroke is one of the most common problems of the nervous system, caused when a section of the brain is deprived of oxygen. It can result in paralysis, vision loss, speech difficulty, and cognitive impairment, as well as other health issues. Early treatment is essential for minimizing long-term damage. Multiple sclerosis is an autoimmune disorder that can cause inflammation of the nerves and impaired function of the muscles. This condition typically develops in young adults and can lead to disability without proper care. Parkinson’s disease is a neurological disorder characterized by a lack of dopamine in the brain, which affects movement and coordination. The symptoms of Parkinson’s include tremors, stiff muscles, and difficulty with balance and gait. Motor neuron disease (MND) is also known as amyotrophic lateral sclerosis (ALS). This disorder affects the nerve cells in the brain and the spine, resulting in muscle weakness, paralyzation, and eventually, death. Finally, epilepsy is a chronic disorder that is caused by abnormal electrical activities in the brain. It’s characterized by seizures that can be mild or severe, depending on the type of disorder. Early diagnosis and treatment of epilepsy significantly reduces the risk of severe neurological complications.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States